Idiomas Español
Activos compatibles
HIMSc logo

Hims & Hers

Antes de apertura

Abrir Mo

26,33 US$

-en el período seleccionado

+0,625 US$ (+2,43 %)desde el cierre de EE. UU.

Precio onchain
-
Prima / descuento
-
Actualizado Referencia

Diferencias de precio antes de comisiones y costes de ejecución. Comparar precios

Análisis

Hims & Hers debate centers on renewed growth versus margin pressure. Legal and cash flow stress test whether scale can offset costs.

Growth durability versus margin pressure

TIKR.com reports revenue projected to reach around $3.2 billion in 2026 and roughly $4.8 billion by 2029, with forward 2-year revenue growth around 30%. Seeking Alpha says international expansion and branded GLP-1 partnerships have accelerated subscriber growth and supported raised FY2026 revenue guidance.

TIKR.com says consensus expects 2030 revenue to land slightly below the 2029 figure, pointing to how much growth survives if compounded GLP-1 revenue fades and branded weight loss competitors ramp up direct-to-consumer efforts. Seeking Alpha says the Eucalyptus acquisition and expanded branded GLP-1 offerings triggered deteriorating profit margins.

Hims & Hers Stock: 30% Growth Can’t Hide a Margin Problem | TIKR.comHims & Hers Goes Global - Renewed Growth Prospects With Margin Risks (NYSE:HIMS) | Seeking AlphaHims & Hers Stock: 30% Growth Can’t Hide a Margin Problem | TIKR.comHims & Hers Goes Global - Renewed Growth Prospects With Margin Risks (NYSE:HIMS) | Seeking Alpha

Legal, privacy, and billing exposure

TradeVae says international rollouts and better-than-expected revenue growth are primary upside catalysts, with marketing efficiency also highlighted. Seeking Alpha says Q2 results showed 38% y/y revenue growth and nearly 3M subscribers, while growth momentum and diversified expansion weigh on reputational concerns.

TradeVae says FTC litigation and advertising privacy concerns could force higher operating costs or slow user acquisition. Seeking Alpha says risks include FTC litigation and billing disputes, while management has flagged weaker margins and pressure on cash flow in the near term.

Hims & Hers Goes Global: Growth Re-Acceleration but Margin Volatility LoomsHims & Hers: U.S. Revenue Reacceleration Is Reassuring; Compelling Valuation Compression | Seeking AlphaHims & Hers Goes Global: Growth Re-Acceleration but Margin Volatility LoomsHims & Hers: U.S. Revenue Reacceleration Is Reassuring; Compelling Valuation Compression | Seeking Alpha

Cash flow and integration costs

Simply Wall St says Hims & Hers Health reported 38% revenue growth after acquiring Eucalyptus and raised full year guidance. Seeking Alpha says the yet profitable Eucalyptus acquisition and expanded branded GLP-1 offerings support the enlarged platform and raised FY2026 revenue guidance.

Simply Wall St says the margin and cash flow squeeze from integration costs, tech investment, and international expansion may not be a one-quarter issue. Seeking Alpha says adjusted EBITDA declined 27% YoY and free cash flow turned negative $68M, signaling deteriorating operating leverage.

Revenue Growth Might Change The Case For Investing In Hims & Hers Health Stock (HIMS) - Simply Wall St NewsHims & Hers Goes Global - Renewed Growth Prospects With Margin Risks (NYSE:HIMS) | Seeking AlphaRevenue Growth Might Change The Case For Investing In Hims & Hers Health Stock (HIMS) - Simply Wall St NewsHims & Hers: Pivot To Branded Distribution Is Eating The Margins Alive (NYSE:HIMS) | Seeking Alpha

Noticias

Token

Token
HIMSc
Acciones por token
1.00000000 HIMS
Contrato
0xb20000000000000000000043a599976181bcf336

Consigue Mo

Guárdalo en Mo

Mantén HIMSc en una billetera inteligente de Mo en Base que tú controlas.

Muévelo rápido

Envía HIMSc a otro usuario de Mo sin comisiones, o a cualquier billetera compatible en Base casi al instante.

Tu dinero. Más posibilidades.